FGLpeptide The DNSP peptide, specifically Dopamine Neuron Stimulating Peptide-11 (DNSP-11), is an 11-amino acid synthetic peptide derived from the pro-domain of Glial Cell Line-Derived Neurotrophic Factor (GDNF). Research indicates that DNSP-11 possesses neurotrophic and neuroprotective properties, particularly concerning dopamine neurons. Its ability to stimulate dopamine neuron function and protect these vital cells from damage is a key area of scientific investigation.The peptide Acein promotes dopamine secretion through clec ... Studies have explored its potential therapeutic actions, including its capacity to promote cell survival, enhance neurite outgrowth, and activate neuroprotective signaling pathways like ERK1/2. Furthermore, the potential for intranasal delivery of DNSP-11 to the central nervous system is being investigated as a promising administration route for its therapeutic benefits.
DNSP-11's neuroprotective effects appear to stem from its interaction with cellular signaling pathways crucial for neuronal health. Research has demonstrated that a single treatment with DNSP-11 can lead to the phosphorylation of ERK1/2 in dopaminergic neuronal cell lines. This activation of the ERK signaling pathway is often associated with cell survival, proliferation, and differentiation, suggesting a novel cellular mechanism through which DNSP-11 exerts its beneficial effects. Moreover, DNSP-11 has shown efficacy in protecting human dopaminergic neuroblastoma cells against apoptotic cell death, a critical process implicated in neurodegenerative diseasesDopamine Neuron Stimulating Peptide-11 Protection From .... This protection extends to mitigating damage caused by neurotoxins like 6-OHDA, a common model used to study Parkinson's disease.
The potential therapeutic applications of DNSP-11 are a significant focus of research. Its ability to stimulate dopamine neuron function and protect against neuronal loss makes it a candidate for conditions affecting the dopaminergic system.DNSP-11 trifluoroacetate salt, | D8571-1MG Beyond traditional administration routes, the intranasal delivery of DNSP-11 is gaining attention. Studies suggest that this method can effectively deliver the peptide to the central nervous system, maintaining its neuroactive properties. This non-invasive approach holds promise for a more accessible and potentially safer therapeutic strategy for various neurological conditions作者：JL Fuqua·2014·被引用次数：17—Glial cell-line derived neurotrophic factor (GDNF) has demonstrated robust effects on dopamine (DA) neuron function and survival..
While DNSP-11 is a prominent subject, other related peptides are also being explored for their impact on dopamine neuron function. For instance, DNSP-5, another synthetic peptide based on the GDNF sequence, has also shown neuroprotective and dopamine-stimulating effects. The characterization of these various DNSP peptides, including DNSP-17, aims to identify their specific stabilities and protective profiles, potentially leading to the development of tailored therapeutic agents. Ongoing research continues to unravel the full spectrum of DNSP-11's actions and its potential to address unmet needs in neurological health.
Join the newsletter to receive news, updates, new products and freebies in your inbox.